Product Images Capecitabine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Capecitabine NDC 16714-467 by Northstar Rxllc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Each tablet of this medication contains Capecitabine USP 150 mg, which is a cytotoxic agent. It must be dispensed in tight containers and stored at 25°C (77°F), with excursions permitted between 15° to 30°C (59° to 86°F). For dosage recommendations and further information, consult the accompanying insert. The pharmacist is required to dispense the medication with a patient information leaflet. The manufacturing license number is G/1339, and it is manufactured for Northstar Rx LLC, Memphis, TN 38141, by Intas Pharmaceuticals Ltd., Ahmedabad-382 210, INDIA. The details for overcoding, Lot, EXP, and Data matrix are supposed to be entered on a varnish-free and blank area on the medication packaging.*
Each tablet contains Capecitabine USP 500 mg. The tablets are a cytotoxic agent and should be dispensed in tight containers as defined in USP/NF. They should be stored at 25°C (77°F) with excursions permitted to 15°t0 30°C (59° to 86°F). The tablets should be kept tightly closed and dispensed with a patient information leaflet by a pharmacist. Dosage recommendations and other important prescribing information can be found in the accompanying insert. The tablets are manufactured by Intas Pharmaceuticals Ltd. in Ahmedabad-382 210, INDIA and are distributed by Northstar Rx LLC in Memphis, TN. The NDC number for the tablets is 16714-468-01.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.